Ignite Creation Date:
2024-05-06 @ 2:09 PM
Last Modification Date:
2024-10-26 @ 1:25 PM
Study NCT ID:
NCT04224896
Status:
COMPLETED
Last Update Posted:
2020-01-13
First Post:
2020-01-08
Brief Title:
Narrow-Band Imaging NBI Versus Lugol Chromoendoscopy in the Detection of Oesophagus Squamous Cell Carcinoma in High Risk Population
Sponsor:
Hôpital Edouard Herriot
Organization:
Hôpital Edouard Herriot
Study Overview
Official Title:
Narrow-Band Imaging NBI Versus Lugol Chromoendoscopy in the Detection of Oesophagus Squamous Cell Carcinoma in High Risk Population a Randomised Controlled Multicentre Trial
Status:
COMPLETED
Status Verified Date:
2020-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Narrow-Band Imaging NBI is as sensitive as Lugol chromoendoscopy to detect oesophageal squamous cell carcinoma SCC and appears more specific than Lugol chromoendoscopy in expert centres but its specificity in current practice is not known This study aimed to prove the superiority of NBI specificity over Lugol chromoendoscopy to detect oesophageal SCC and high-grade dysplasia HGD in current practice including tertiary care centres local hospitals and private clinics
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None